These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1425944)

  • 1. Effects of YM435, a novel dopamine D1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Ren LM; Chiba S
    Eur J Pharmacol; 1992 Aug; 218(2-3):237-41. PubMed ID: 1425944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Hypertens Res; 1995 Jun; 18 Suppl 1():S173-4. PubMed ID: 8529053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S
    J Pharmacol Exp Ther; 1989 Aug; 250(2):734-9. PubMed ID: 2474643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
    Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
    Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
    Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.
    Yatsu T; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1997 Aug; 29(2):229-32. PubMed ID: 9251904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs.
    Yatsu T; Miyamoto I; Kaneko-Takanuki F; Watanabe T; Takenaka T
    J Pharm Pharmacol; 1997 Sep; 49(9):892-6. PubMed ID: 9306257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtypes of adenosine receptors on pancreatic exocrine secretion in anaesthetized dogs.
    Iwatsuki K
    Fundam Clin Pharmacol; 2000; 14(3):203-8. PubMed ID: 15602796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peptide histidine isoleucine on pancreatic exocrine secretion in anaesthetized dogs.
    Iwatsuki K; Ren LM; Chiba S
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):501-7. PubMed ID: 8403531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect stimulation of pancreatic exocrine secretion by neurotensin in anaesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):475-81. PubMed ID: 1914248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of central dopamine on basal pancreatic secretion in conscious rats.
    Masuda M; Kanai S; Miyasaka K
    Am J Physiol; 1998 Jan; 274(1):G29-34. PubMed ID: 9458770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.
    Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1998 Nov; 31(5):803-7. PubMed ID: 9809482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of D1 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
    Péczely L; Ollmann T; László K; Kovács A; Gálosi R; Szabó Á; Karádi Z; Lénárd L
    Behav Brain Res; 2014 Aug; 270():131-6. PubMed ID: 24815313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
    Takenaka T; Forster H; Epstein M
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1154-9. PubMed ID: 8095547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.
    Yatsu T; Arai Y; Sudoh K; Shibasaki M; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1998 May; 30(5):733-7. PubMed ID: 9559326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
    Wong AO; Chang JP; Peter RE
    Endocrinology; 1992 Mar; 130(3):1201-10. PubMed ID: 1347006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.